ORMDL3 and inflammatory bowel disease: Although genome-wide association studies (GWAS) have implicated the orosomucoid-like protein 3 (ORMDL3), also known as ORMDL sphingolipid biosynthesis regulator 3, in susceptibility to both IBD and DM, its precise role in diabetes-associated intestinal alterations remains poorly defined.